GRADE II NEUROENDOCRINE CARCINOMA

Clinical trials for GRADE II NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new GRADE II NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for GRADE II NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New combo therapy tested for Tough-to-Treat cancers that have returned

Disease control Ongoing

This study is testing whether combining two existing drugs—nivolumab (an immunotherapy) and temozolomide (a chemotherapy)—can help control cancers that have come back or stopped responding to standard treatments. It is for adults with recurrent small-cell lung cancer or advanced …

Matched conditions: GRADE II NEUROENDOCRINE CARCINOMA

Phase: PHASE2 • Sponsor: Dwight Owen • Aim: Disease control

Last updated Feb 23, 2026 14:56 UTC

GRADE II NEUROENDOCRINE CARCINOMA

Get alerted when new GRADE II NEUROENDOCRINE CARCINOMA trials appear

New combo therapy tested for Tough-to-Treat cancers that have returned